Arsenic possibly influences carcinogenesis by affecting arginine and zinc metabolism.

The role of arsenic in carcinogenesis is controversial. There is no doubt arsenic can influence carcinogenesis under certain conditions. However, a review of the findings relating arsenic to cancer indicates that arsenic mainly affects carcinogenesis indirectly by influencing other metabolic systems (i.e., immune system) or nutrients (i.e., arginine, zinc) that may have a more direct role in the carcinogenic process. Depending upon the level of exposure, arsenic can either inhibit or activate interferon, an inhibitor of virus replication. Furthermore, arsenic can apparently inhibit some virusinduced tumorigenesis. However, once a tumor is initiated, arsenic enhances tumor growth, possibly by affecting the immune response. Recent experiments in our laboratory demonstrated that arsenic metabolically interacts with arginine and zinc, both of which apparently influence the immune response. Arsenic evidently has a role that strongly influences the metabolism of arginine, which is an immunostimulatory amino acid. Furthermore, the effect of arsenic on arginine metabolism is apparently modified by the zinc status of the animal. Because arsenic can apparently affect cancer development through several indirect or direct mechanisms, probably the only general conclusion that can be made about arsenic and cancer is that arsenic, depending upon dosage, route of administration, and chemical form, modifies the induction or development of some tumors.